What's in Pharmicell Co., Ltd.'s pipeline?

Pharmicell Co., Ltd. has 5 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Pharmicell Co., Ltd.'s portfolio?

Top competitors by shared drug class: Avicenna Research Institute, BicycleTx Limited, Biosolution Co., Ltd., Bone Therapeutics S.A, Brainstorm-Cell Therapeutics.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/pharmicell-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Pharmicell Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pharmicell Co., Ltd. pipeline: 0 marketed, 0 filed, 2 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Hearticellgram-AMI	Hearticellgram-AMI	phase 3	Cell therapy		Cardiovascular
Cellgram-LC	Cellgram-LC	phase 3	Allogeneic mesenchymal stem cell therapy		Immunology / Regenerative Medicine

Therapeutic area mix

Cardiovascular · 1
Gastroenterology · 1
Immunology / Regenerative Medicine · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Avicenna Research Institute · 1 shared drug class
BicycleTx Limited · 1 shared drug class
Biosolution Co., Ltd. · 1 shared drug class
Bone Therapeutics S.A · 1 shared drug class
Brainstorm-Cell Therapeutics · 1 shared drug class
Celavie Bioscences, LLC · 1 shared drug class
Cell Biopeutics Resources Sdn Bhd · 1 shared drug class
Anterogen Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Pharmicell Co., Ltd.:

Cite this brief

Drug Landscape (2026). Pharmicell Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/pharmicell-co-ltd. Accessed 2026-06-10.